These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 787723)

  • 1. The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part IV of IV parts: The state of the bones in uremic hyperaparathyroidism--the mechanisms of skeletal resistance to PTH in renal failure and pseudohypoparathyroidism and the role of PTH in osteoporosis, osteopetrosis, and osteofluorosis.
    Parfitt AM
    Metabolism; 1976 Oct; 25(10):1157-88. PubMed ID: 787723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry.
    Parfitt AM
    Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):387-403. PubMed ID: 12815335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P
    APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sensitivity of bone to parathyroid hormone in type I pseudohypoparathyroidism. 6 cases].
    Wemeau JL; Duquesnoy B; Grimbert I; Hubaud P; Hardouin P; Lemaitre G; Fossati P; Decoulx M
    Ann Med Interne (Paris); 1986; 137(3):220-5. PubMed ID: 3767189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part III of IV parts; PTH and osteoblasts, the relationship between bone turnover and bone loss, and the state of the bones in primary hyperparathyroidism.
    Parfitt AM
    Metabolism; 1976 Sep; 25(9):1033-69. PubMed ID: 785157
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone diseases. II. PTH and bone cells: bone turnover and plasma calcium regulation.
    Parfitt AM
    Metabolism; 1976 Aug; 25(8):909-55. PubMed ID: 181659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium and phosphorus metabolism in chronic uremia.
    Fiaschi E; Mioni G; Maschio G; D'Angelo A; Ossi E
    Nephron; 1975; 14(2):163-80. PubMed ID: 1093055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part I of IV parts: mechanisms of calcium transfer between blood and bone and their cellular basis: morphological and kinetic approaches to bone turnover.
    Parfitt AM
    Metabolism; 1976 Jul; 25(7):809-44. PubMed ID: 781470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of 1,25-dihydroxyvitamin D on the skeletal resistance to parathyroid hormone.
    Galceran T; Martin KJ; Morrissey JJ; Slatopolsky E
    Kidney Int; 1987 Dec; 32(6):801-7. PubMed ID: 3430963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vitamin D metabolism in kidney insufficiency: disorders of an endocrine regulatory zone].
    Ritz E; Kreusser W; Boland R; Bommer J
    Klin Wochenschr; 1979 Oct; 57(19):1053-9. PubMed ID: 392179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary hyperparathyroidism with 1,25-dihydroxyvitamin D deficiency and pseudohypoparathyroidism in childhood: relationship between plasma 1,25-dihydroxyvitamin D and parathyroid hormone levels and urinary cyclic AMP response to exogenous PTH.
    Seino Y; Ishida M; Yamaoka K; Shimotsuji T; Ishii T; Yabuuchi H; Fukase M; Fujita T
    Eur J Pediatr; 1981 Feb; 135(3):267-71. PubMed ID: 6262082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normocalcaemic pseudohypoparathyroidism with unusual phenotype.
    Gertner JM; Tomlinson S; Gonzalez-Macias J
    Arch Dis Child; 1978 Apr; 53(4):312-5. PubMed ID: 646442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic bone disease in pseudohypoparathyroidism: radiologic features.
    Burnstein MI; Kottamasu SR; Pettifor JM; Sochett E; Ellis BI; Frame B
    Radiology; 1985 May; 155(2):351-6. PubMed ID: 3983385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment.
    Kruse K; Kracht U; Wohlfart K; Kruse U
    Eur J Pediatr; 1989 Apr; 148(6):535-9. PubMed ID: 2744015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudohypoparathyroidism with osteitis fibrosa cystica: direct demonstration of skeletal responsiveness to parathyroid hormone in cells cultured from bone.
    Murray TM; Rao LG; Wong MM; Waddell JP; McBroom R; Tam CS; Rosen F; Levine MA
    J Bone Miner Res; 1993 Jan; 8(1):83-91. PubMed ID: 8427051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial changes in bone mineral density and bone turnover after correction of secondary hyperparathyroidism in a patient with pseudohypoparathyroidism type Ib.
    Tollin SR; Perlmutter S; Aloia JF
    J Bone Miner Res; 2000 Jul; 15(7):1412-6. PubMed ID: 10893692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoparathyroidism.
    Breslau NA; Pak CY
    Metabolism; 1979 Dec; 28(12):1261-76. PubMed ID: 390300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uremic toxin and bone metabolism.
    Iwasaki Y; Yamato H; Nii-Kono T; Fujieda A; Uchida M; Hosokawa A; Motojima M; Fukagawa M
    J Bone Miner Metab; 2006; 24(2):172-5. PubMed ID: 16502128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.